ArticleNanomaterials (Basel, Switzerland)2026
A Lab-on-a-Chip for the Extraction and Analysis of Single Molecules of DNA from Biological Media.
Article in Nanomaterials (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
DNA extraction is a critical prerequisite for reliable downstream analyses such as Polymerase Chain Reaction (PCR), sequencing, and genotyping. Conventional methods often require labor-intensive protocols, large sample volumes, or costly automation. Microfluidic approaches offer an alternative by reducing reagent consumption and enabling faster, more integrated workflows. Here, we present a passive lab-on-a-chip device that performs DNA extraction from complex biological media and enables subsequent on-chip single-molecule analysis. The chip integrates a magnetophoresis-based solid-phase extraction module with a fluorescence detection section capable of quantifying DNA molecules in microchannels and visualizing stretched molecules in nanochannels. The multi-level micro/nanofluidic architecture is fabricated in polymer using a single-step nanoimprinting process with a total manufacturing time of two minutes per chip, enabling scalable production. As a proof of concept, the device extracted DNA from samples spiked into buffer or plasma. On-chip transfer efficiency of DNA-bead complexes to the elution buffer reached 86%, and quantitative analysis of the recovered liquid showed an overall extraction efficiency of 40% (including DNA recovery off-chip), with intact 48 kbp DNA confirmed in both micro- and nanochannel measurements. This platform offers a promising foundation for point-of-care and point-of-interest applications, where integrated DNA extraction and analysis can reduce sample loss and support streamlined, automated workflows.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.